内分泌肿瘤-话题@MedSci - williamhill asia

#内分泌肿瘤#

88篇内容 | 1736人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1763528, encodeId=b2321e635283e, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=Nature Cancer：CAR-T治疗神经内分泌肿瘤和胃肠间质瘤的安全靶点——CDH17（LI钙粘蛋白）, objectType=article, longId=723586, objectId=f925e23586f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f925e23586f7, replyNumber=0, likeNumber=74, createdTime=2022-09-21, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f925e23586f7, moduleTitle=Nature Cancer：CAR-T治疗神经内分泌肿瘤和胃肠间质瘤的安全靶点——CDH17（LI钙粘蛋白）, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=f925e23586f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763529, encodeId=9c121e63529cc, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=European Radiology：基于深度学习的超声列线图模型在术前预测胰腺神经内分泌肿瘤侵袭性中的应用, objectType=article, longId=735723, objectId=c9c9e35723e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9c9e35723e8, replyNumber=0, likeNumber=74, createdTime=2022-10-28, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9c9e35723e8, moduleTitle=European Radiology：基于深度学习的超声列线图模型在术前预测胰腺神经内分泌肿瘤侵袭性中的应用, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=c9c9e35723e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763527, encodeId=c2d41e635278c, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=JGH: 内镜下切除非壶腹十二指肠神经内分泌肿瘤的长期预后比较好, objectType=article, longId=294089, objectId=2ec7294089df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ec7294089df, replyNumber=0, likeNumber=81, createdTime=2022-07-28, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ec7294089df, moduleTitle=JGH: 内镜下切除非壶腹十二指肠神经内分泌肿瘤的长期预后比较好, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=2ec7294089df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763525, encodeId=2aef1e6352575, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=JAMA Netw Open：库欣综合征相关肺神经内分泌肿瘤的外科治疗结局特征, objectType=article, longId=218643, objectId=c26f2186436d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c26f2186436d, replyNumber=0, likeNumber=78, createdTime=2021-11-23, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c26f2186436d, moduleTitle=JAMA Netw Open：库欣综合征相关肺神经内分泌肿瘤的外科治疗结局特征, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=c26f2186436d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763524, encodeId=642c1e63524d3, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=JNCCN：卡培他滨/替莫唑胺(CAPTEM)治疗神经内分泌肿瘤的疗效和安全性, objectType=article, longId=216808, objectId=6a23216808c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a23216808c1, replyNumber=0, likeNumber=72, createdTime=2021-09-25, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a23216808c1, moduleTitle=JNCCN：卡培他滨/替莫唑胺(CAPTEM)治疗神经内分泌肿瘤的疗效和安全性, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=6a23216808c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763523, encodeId=6b391e63523b0, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=2020年ESMO威廉亚洲博彩公司 : 胃肠胰神经内分泌肿瘤的诊治和随访, objectType=article, longId=215753, objectId=f337215e53c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f337215e53c3, replyNumber=0, likeNumber=78, createdTime=2022-07-26, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f337215e53c3, moduleTitle=2020年ESMO威廉亚洲博彩公司 : 胃肠胰神经内分泌肿瘤的诊治和随访, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=f337215e53c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763526, encodeId=b5631e635265d, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=陈洁：2021年ESMO年会我感兴趣的神经内分泌肿瘤相关摘要, objectType=article, longId=292477, objectId=9e8a2924e7c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e8a2924e7c2, replyNumber=0, likeNumber=132, createdTime=2022-08-10, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e8a2924e7c2, moduleTitle=陈洁：2021年ESMO年会我感兴趣的神经内分泌肿瘤相关摘要, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=9e8a2924e7c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763522, encodeId=1b371e63522f6, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=JNCCN：神经内分泌肿瘤（NETs）患者肿瘤特异性死亡的风险, objectType=article, longId=212389, objectId=b21d21238921, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b21d21238921, replyNumber=0, likeNumber=69, createdTime=2021-08-10, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b21d21238921, moduleTitle=JNCCN：神经内分泌肿瘤（NETs）患者肿瘤特异性死亡的风险, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=b21d21238921)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763530, encodeId=052e1e63530e4, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=【CLEAR柯丽尔每日一例】功能性直肠神经内分泌肿瘤并慢性肾衰, objectType=article, longId=288459, objectId=6f7928845978, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f7928845978, replyNumber=0, likeNumber=64, createdTime=2022-08-20, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f7928845978, moduleTitle=【CLEAR柯丽尔每日一例】功能性直肠神经内分泌肿瘤并慢性肾衰, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=6f7928845978)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763520, encodeId=91ff1e63520fb, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=JCO：乐伐替尼或可用于治疗晚期胃肠道胰腺神经内分泌肿瘤！, objectType=article, longId=211131, objectId=ac0a21113198, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac0a21113198, replyNumber=0, likeNumber=73, createdTime=2022-04-10, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac0a21113198, moduleTitle=JCO：乐伐替尼或可用于治疗晚期胃肠道胰腺神经内分泌肿瘤！, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=ac0a21113198)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763517, encodeId=2c521e6351763, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=Chi-Med公司开始向美国FDA递交Surufatinib治疗晚期神经内分泌肿瘤的申请, objectType=article, longId=204981, objectId=5ad92049818f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ad92049818f, replyNumber=0, likeNumber=67, createdTime=2021-01-04, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ad92049818f, moduleTitle=Chi-Med公司开始向美国FDA递交Surufatinib治疗晚期神经内分泌肿瘤的申请, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=5ad92049818f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763516, encodeId=c25c1e635166d, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=TAG：二甲双胍在胰腺神经内分泌肿瘤患者治疗中的潜在作用, objectType=article, longId=200571, objectId=ff2d2005e105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff2d2005e105, replyNumber=0, likeNumber=65, createdTime=2020-10-04, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff2d2005e105, moduleTitle=TAG：二甲双胍在胰腺神经内分泌肿瘤患者治疗中的潜在作用, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=ff2d2005e105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763521, encodeId=0abf1e63521f5, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=JNNP：神经内分泌肿瘤与非神经内分泌肿瘤患者免疫检查点抑制剂相关神经病变的比较, objectType=article, longId=212037, objectId=a30b21203e71, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a30b21203e71, replyNumber=0, likeNumber=59, createdTime=2022-02-07, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a30b21203e71, moduleTitle=JNNP：神经内分泌肿瘤与非神经内分泌肿瘤患者免疫检查点抑制剂相关神经病变的比较, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=a30b21203e71)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763519, encodeId=a9311e635193e, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=BMC Gastroenterology：miRNA-202-3p是诊断1型胃神经内分泌肿瘤的潜在新生物标志物, objectType=article, longId=210733, objectId=d891210e3325, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d891210e3325, replyNumber=0, likeNumber=62, createdTime=2022-02-13, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d891210e3325, moduleTitle=BMC Gastroenterology：miRNA-202-3p是诊断1型胃神经内分泌肿瘤的潜在新生物标志物, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=d891210e3325)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763515, encodeId=c4991e63515c2, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=晚期神经内分泌肿瘤的治疗或迎新进展！和记黄埔已向EMA提交Surufatinib的营销授权申请, objectType=article, longId=199177, objectId=3bc11991e7f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bc11991e7f6, replyNumber=0, likeNumber=59, createdTime=2020-08-19, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bc11991e7f6, moduleTitle=晚期神经内分泌肿瘤的治疗或迎新进展！和记黄埔已向EMA提交Surufatinib的营销授权申请, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=3bc11991e7f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763511, encodeId=d0881e635119e, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=和记黄埔的Surufatinib获得FDA授予快速通道指定，用于治疗胰腺和非胰腺神经内分泌肿瘤, objectType=article, longId=192484, objectId=fb0c19248469, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb0c19248469, replyNumber=0, likeNumber=77, createdTime=2021-01-13, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb0c19248469, moduleTitle=和记黄埔的Surufatinib获得FDA授予快速通道指定，用于治疗胰腺和非胰腺神经内分泌肿瘤, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=fb0c19248469)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763518, encodeId=44101e635182a, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=子宫颈神经内分泌肿瘤诊疗, objectType=article, longId=206106, objectId=3478206106f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3478206106f6, replyNumber=0, likeNumber=75, createdTime=2021-10-07, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3478206106f6, moduleTitle=子宫颈神经内分泌肿瘤诊疗, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=3478206106f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763514, encodeId=48551e6351477, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=多发性内分泌肿瘤综合征丨影像诊断, objectType=article, longId=196341, objectId=5f5419634113, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f5419634113, replyNumber=0, likeNumber=77, createdTime=2020-11-03, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f5419634113, moduleTitle=多发性内分泌肿瘤综合征丨影像诊断, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=5f5419634113)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763512, encodeId=fd651e6351269, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=BMC Endocr Disord：转移部位对神经内分泌肿瘤（NEN）患者生存的影响, objectType=article, longId=192857, objectId=263019285ed3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=263019285ed3, replyNumber=0, likeNumber=62, createdTime=2021-01-26, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=263019285ed3, moduleTitle=BMC Endocr Disord：转移部位对神经内分泌肿瘤（NEN）患者生存的影响, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=263019285ed3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763506, encodeId=3d9a1e63506fa, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=Ipsen在英国推出了新的自注射Somatuline，治疗胃肠胰神经内分泌肿瘤, objectType=article, longId=177385, objectId=0ec61e738551, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ec61e738551, replyNumber=0, likeNumber=75, createdTime=2019-12-27, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ec61e738551, moduleTitle=Ipsen在英国推出了新的自注射Somatuline，治疗胃肠胰神经内分泌肿瘤, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=0ec61e738551)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] williamhill asia 话题小助手

内分泌肿瘤

2020-05-29

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

Nature Cancer：CAR-T治疗神经内分泌肿瘤和胃肠间质瘤的安全靶点——CDH17（LI钙粘蛋白）

2022-09-21

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

European Radiology：基于深度学习的超声列线图模型在术前预测胰腺神经内分泌肿瘤侵袭性中的应用

2022-10-28

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

JGH: 内镜下切除非壶腹十二指肠神经内分泌肿瘤的长期预后比较好

2022-07-28

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

JAMA Netw Open：库欣综合征相关肺神经内分泌肿瘤的外科治疗结局特征

2021-11-23

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

JNCCN：卡培他滨/替莫唑胺(CAPTEM)治疗神经内分泌肿瘤的疗效和安全性

2021-09-25

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

2020年ESMO威廉亚洲博彩公司 : 胃肠胰神经内分泌肿瘤的诊治和随访

2022-07-26

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

陈洁：2021年ESMO年会我感兴趣的神经内分泌肿瘤相关摘要

2022-08-10

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

JNCCN：神经内分泌肿瘤（NETs）患者肿瘤特异性死亡的风险

2021-08-10

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

【CLEAR柯丽尔每日一例】功能性直肠神经内分泌肿瘤并慢性肾衰

2022-08-20

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

JCO：乐伐替尼或可用于治疗晚期胃肠道胰腺神经内分泌肿瘤！

2022-04-10

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

Chi-Med公司开始向美国FDA递交Surufatinib治疗晚期神经内分泌肿瘤的申请

2021-01-04

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

TAG：二甲双胍在胰腺神经内分泌肿瘤患者治疗中的潜在作用

2020-10-04

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

JNNP：神经内分泌肿瘤与非神经内分泌肿瘤患者免疫检查点抑制剂相关神经病变的比较

2022-02-07

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

BMC Gastroenterology：miRNA-202-3p是诊断1型胃神经内分泌肿瘤的潜在新生物标志物

2022-02-13

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

晚期神经内分泌肿瘤的治疗或迎新进展！和记黄埔已向EMA提交Surufatinib的营销授权申请

2020-08-19

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

和记黄埔的Surufatinib获得FDA授予快速通道指定，用于治疗胰腺和非胰腺神经内分泌肿瘤

2021-01-13

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

子宫颈神经内分泌肿瘤诊疗

2021-10-07

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

多发性内分泌肿瘤综合征丨影像诊断

2020-11-03

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

BMC Endocr Disord：转移部位对神经内分泌肿瘤（NEN）患者生存的影响

2021-01-26

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

Ipsen在英国推出了新的自注射Somatuline，治疗胃肠胰神经内分泌肿瘤

2019-12-27

科室
- - 订阅+
  - 更多科室
工具
服务